Skip to main content

Advertisement

Log in

Accurately quantified plasma free glycine concentration as a biomarker in patients with acute ischemic stroke

  • Original Article
  • Published:
Amino Acids Aims and scope Submit manuscript

Abstract

We developed a hollow fiber centrifugal ultrafiltration (HFCF-UF) method to study the change of plasma levels of free glycine (Gly) in patients with acute ischemic stroke (AIS). Twenty-four patients with AIS confirmed by diffusion-weighted imaging (DWI) were enrolled. During the study period, the patients did not receive any supplemental amino acids therapy that could affect the obtained results. Our results showed that although AIS patients adopted different methods of treatment (thrombolytic and non-thrombolytic), the clinical NIHSS score of AIS showed a downward trend whereas Gly concentration showed increased trend. Moreover, plasma free Gly concentration was positively correlated with ASPECTS score. The correlation between Gly levels and infarct volume showed a statistical significance. That is to say, higher Gly level predicted smaller infarct size. Thus, the change of free Gly level in plasma could be considered as a potential biomarker of AIS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

Data availability

All data generated or analyzed during this study are included in this published article.

References

Download references

Funding

This study was supported by the Natural Science Foundation of Hebei Province [grant numbers H2021206299].

Author information

Authors and Affiliations

Authors

Contributions

The study conception and design, acquisition of data, and first draft of the manuscript were performed by HW. The authors XN and WD helped in the acquisition of data, material preparation, respectively. WQ and LX helped in the collection of clinical plasma sample. YJ and LX are responsible for the guidance of the method part and the clinical part, respectively. All authors contributed to the final version of the manuscript.

Corresponding authors

Correspondence to Lei Xu or Ye Jiang.

Ethics declarations

Conflict of interest

There are no conflict of interest among any of the authors related to this manuscript.

Ethical statement

The study protocol was approved by the ethics committee of The Second Hospital of Hebei Medical University, in accordance with the ethical guidelines of the 1975 Declaration of Helsinki. Written consent was obtained from all the patients. Research Ethics Committee Ethical Approval number: 2022-R318.

Additional information

Handling editor: T. Bohn.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, H., Ni, X., Dong, W. et al. Accurately quantified plasma free glycine concentration as a biomarker in patients with acute ischemic stroke. Amino Acids 55, 385–402 (2023). https://doi.org/10.1007/s00726-023-03236-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00726-023-03236-x

Keywords

Navigation